CIK 0001178670
- Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770602661
- Phone
- +1 617-551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $543,126
- in 2 filings
- Open-market sales, last 90 days
- $398,855
- in 1 filing
Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-03 | Greenstreet Yvonne Chief Executive Officer | Grant or award | +3,859 | 26,997 | ||
| 2022-07-05 | Tanguler Tolga EVP, Chief Commercial Officer | Sale | −1,754 | $150.00 | $263K | 1,754 |
| 2022-05-18 | PYOTT DAVID E I Director | Grant or award · Stock Option (right to buy) | +5,153 | 5,153 | ||
| 2022-05-18 | BRANDICOURT OLIVIER Director | Grant or award · Stock Option (right to buy) | +5,153 | 5,153 | ||
| 2022-05-18 | HAMBURG MARGARET A Director | Grant or award · Stock Option (right to buy) | +5,153 | 5,153 | ||
| 2022-05-18 | Reitan Colleen F Director | Grant or award · Stock Option (right to buy) | +5,153 | 5,153 | ||
| 2022-05-18 | SCHULMAN AMY W Director | Grant or award · Stock Option (right to buy) | +5,153 | 5,153 | ||
| 2022-05-18 | Ausiello Dennis A Director | Grant or award · Stock Option (right to buy) | +5,153 | 5,153 | ||
| 2022-05-18 | Fanucci Marsha Director | Grant or award · Stock Option (right to buy) | +5,153 | 5,153 | ||
| 2022-05-18 | SHARP PHILLIP A Director | Grant or award · Stock Option (right to buy) | +5,153 | 5,153 | ||
| 2022-04-01 | PAUL STEVEN M Director | Exercise or conversion | +15,000 | $11.33 | $170K | 16,000 |
| 2022-04-01 | PAUL STEVEN M Director | Sale | −253 | $166.04 | $42K | 15,747 |
| 2022-04-01 | PAUL STEVEN M Director | Sale | −4,948 | $168.95 | $836K | 10,799 |
| 2022-04-01 | PAUL STEVEN M Director | Sale | −4,872 | $169.71 | $827K | 5,927 |
| 2022-04-01 | PAUL STEVEN M Director | Sale | −1,235 | $171.16 | $211K | 4,692 |
| 2022-04-01 | PAUL STEVEN M Director | Sale | −1,434 | $172.10 | $247K | 3,258 |
| 2022-04-01 | PAUL STEVEN M Director | Sale | −642 | $173.06 | $111K | 2,616 |
| 2022-04-01 | PAUL STEVEN M Director | Sale | −90 | $174.33 | $16K | 2,526 |
| 2022-04-01 | PAUL STEVEN M Director | Sale | −526 | $176.51 | $93K | 2,000 |
| 2022-04-01 | PAUL STEVEN M Director | Sale | −825 | $177.58 | $147K | 1,175 |
Page 62 of 63 · 1,253 trades